Caris Life Sciences Stock
Caris Life Sciences is a molecular science company developing and delivering technologies to revolutionize healthcare. The Company's suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physicians and researchers improve outcomes and save lives.
Sign up for SecondMarket™ to view the market and buy or sell Caris Life Sciences Stock
Buy + SellSee Caris Life Sciences Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Caris Life Sciences Stock Valuation + Share Prices
View real-time Tape D™ data on Caris Life Sciences stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Caris Life Sciences Management Team
Chairman, Founder, CEO
David Dean Halbert
Director
Vijay Mohan
Director
Jon Halbert
Director
Danny Phillips
Director
Peter Castleman
Director
George Poste
Executive Vice President, Chief of Staff
Stephanie Thomas
Director
Joseph Gilliam
Director
Jonathan Knowles
Director
Lloyd B. Minor
Executive Vice President, Chief Medical Officer
George W. Sledge
Director
Laurie Johansen
President
David Spetzler
Director
Nate Burns
Caris Life Sciences Major Investors
Canada Pension Plan Investment Board (CPPIB)
Braidwell LP
Eaton Vance
TPG Sixth Street Partners
Highland Capital Management, L.P.
Columbia Threadneedle Investments
Tudor Investment Corporation
Millennium Management, LLC
T. Rowe Price Associates, Inc.
First Light Asset Management
ClearBridge Investments, LLC
OrbiMed Advisors LLC
Rock Springs Capital
Silver Lake
Pura Vida Investments
Sixth Street Partners
Fidelity Management & Research Company
Neuberger Berman LLC
Coatue Management LLC
Learn More About Caris Life Sciences Stock
Buy Caris Life Sciences Stock
01Caris Life Sciences stock does not trade on public stock exchanges. Caris Life Sciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Caris Life Sciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Caris Life Sciences Stock
02Caris Life Sciences Stock does not trade on public stock exchanges. In order to sell Caris Life Sciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Caris Life Sciences Stock Price
03Caris Life Sciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Caris Life Sciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
Caris Life Sciences Stock Ticker Symbol
04There is no ticker symbol for Caris Life Sciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Caris Life Sciences Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Caris Life Sciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Caris Life Sciences Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Caris Life Sciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Caris Life Sciences Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Caris Life Sciences IPO
08Caris Life Sciences is a private company and has not had an IPO. There is currently no Caris Life Sciences IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Caris Life Sciences IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Caris Life Sciences Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
